AAAAI

AAAAI 2021: Asthma Not an Independent Predictor of Severe COVID-19 Outcomes
March 05, 2021

Recent research presented at AAAAI 2021 Virtual Annual Meeting suggests asthma is not an independent risk factor for severe COVID-19 or hospitalization.

Significant Reductions in Exacerbations Seen in Broad Population of Severe Asthma Patients
March 01, 2021

Statistically significant reductions in annual exacerbation rates were seen across baseline eosinophil and exhaled FeNO level and allergy status with telepezumab, in the phase 3 NAVIGATOR trial.

Expert-guided Online Decision Tool Supports Real-time Treatment Choice for Severe Asthma
March 01, 2021

Treatment for severe asthma may be enhanced using an online decision support tool that draws on expert treatment decisions for a wide variety of potential patient scenarios.

Asthma Patients with COVID-19 at Comparable Risk of Hospitalization
February 26, 2021

Patients with COVID-19 who have asthma share a similar risk of hospitalization with patients with the infection who do not have asthma, according to new research.

Use of Face Masks Does Not Affect Oxygen Saturation in Asthma Patients
February 25, 2021

AAAAI Virtual Annual Meeting. Among patients with asthma, wearing a mask, regardless of type or duration of use, had no significant effect on oxygen saturation.

AAAAI 2021 Virtual Annual Meeting: A First Look
February 24, 2021

Get a first look at key 8 studies to be presented at the upcoming AAAAI 2021 virtual meeting starting this Friday, February 26, 2021.

Biologic Eliminates or Reduces Oral Steroids in Severe Asthma: PONENTE Trial
February 24, 2021

AAAAI Virtual Annual Meeting. Two-thirds of severe asthma patients dependent upon oral corticosteroids stopped or maximally reduced use, according to the trial data.